Aspirin-exacerbated respiratory disease: Is it in our DNA?

Annals of Allergy, Asthma and Immunology

Volumn 106, Issue 4, 2011, Pages 263-264

  Chang, Jinny ^a   Simon, Ronald A ^a   Stevenson, Donald D ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DNA; G PROTEIN COUPLED RECEPTOR; MONTELUKAST; REGULATOR OF G PROTEIN SIGNALING IN THE R7 SUBFAMILY; RGS PROTEIN; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARACHIDONIC ACID METABOLISM; ASPIRIN EXACERBATED RESPIRATORY DISEASE; DRUG INDUCED DISEASE; EDITORIAL; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; RHINOSINUSITIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASPIRIN; DRUG HYPERSENSITIVITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; RESPIRATORY TRACT DISEASES;

EID: 79953320806     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.12.016     Document Type: Editorial

References (10)

1. Samter M, Beers RF Jr. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68:975-983.
2. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89:474.
3. Palikhe NS, Kim JH, Park HS. Update on recent advances in the management of aspirin exacerbated respiratory disease. Yonsei Med J. 2009;50:744-750.
4. Lee EH, Park BL, Park SM, et al. Association analysis of regulator of G-protein signaling 7 binding protein gene polymorphisms with aspirin intolerance in asthmatic patients. Ann Allergy Asthma Immunol. 2011;106:292-300.
5. Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger J, eds. Allergy: Principle and Practice. Vol 2. St Louis, MO: Mosby-Year Book; 1993:1747-1765.
6. Szczeklik A, Sanak M. Genetic mechanisms in aspirin-induced asthma. Am J Respir Crit Care Med. 2000;161:S142-S146. (Pubitemid 30129433)
7. Van Sambeek R, Stevenson DD, Baldasaro M, et al. 5′ flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol. 2001;107:561-562.
8. De Alarcon AM, Steinke JW, Cughey R, et al. Expression of leukotriene C4 synthase and plasminogen activator inhibitor 1 gene promoter polymorphisms in sinusitis. Am J Rhinol. 2006;20:545-549. (Pubitemid 44575723)
9. Kim SH, Ye YM, Hur GY, et al. CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. Pharmacogenomics. 2007;8:1143-1150. (Pubitemid 47578223)
10. Nizankowska E, Duplaga M, Bechenek G, Szczeklik A. Clinical course of aspirin-induced asthma: results of AIANE. In: Szczeklik A, Gryglewski RJ, Vane JR, eds. Eicosanoids, Aspirin and Asthma. New York, NY: Marcel Dekker; 1998:451-472.